Nov 11, 2025 · Skyrizi (risankizumab) is a prescription medication used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn’s disease, which are chronic inflammatory diseases. …

SKYRIZI is a prescription medicine that may cause serious side effects, including: Serious allergic reactions: Infections: SKYRIZI may lower the ability of your immune system to fight infections and …

Aug 8, 2025 · Skyrizi (risankizumab-rzaa) is a brand-name drug approved to treat plaque psoriasis, Crohn’s disease, and other conditions. Skyrizi works by reducing inflammation associated with these...

May 21, 2025 · SKYRIZI (risankizumab-rzaa) injection is a sterile, preservative-free, colorless to slightly yellow, and clear to slightly opalescent solution for subcutaneous use.

Plaque Psoriasis: SKYRIZI is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

This injection treats symptoms of psoriasis like swelling, itching and rashes. It also treats psoriatic arthritis and Crohn's disease by reducing inflammation. This medication is usually given by a …

Dec 10, 2025 · Skyrizi is typically given once every 8 to 12 weeks. However, your specific Skyrizi dose and frequency will depend on the condition you’re using it to treat. For some conditions, you’ll receive...

Aug 21, 2024 · What is Skyrizi used for? Skyrizi (risankizumab) is commonly used for the following conditions. How Skyrizi Works for Crohn’s Disease. How Skyrizi Works for Plaque Psoriasis. How …

SKYRIZI (Sky-RIZZ-ee; skaɪ rɪz zi), an injection, is known as an interleukin-23 (IL-23) inhibitor. † It works inside your body to treat adults with moderate to severe Ps who can take injections, pills …

May 14, 2025 · Skyrizi (risankizumab) is a type of monoclonal antibody. More specifically, it's an interleukin antagonist. It blocks proteins in your immune system called interleukin-23 (IL-23). These …